Literature DB >> 29596510

Correction: SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0191510.].

Entities:  

Year:  2018        PMID: 29596510      PMCID: PMC5875876          DOI: 10.1371/journal.pone.0195417

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There is information missing from the Funding section. The correct funding information is as follows: This work was funded by Canada Research Chair funds to LS and Leukemia and Lymphoma Society of Canada Grant (#317359) to LS, the Orsino Chair in Leukemia Research, Marvin and Linda Barnett leukemia Research Fund, Brian Steck Leukemia Research Fund to MDM and an Innovation Grant of the Canadian Cancer Society, and Brain Canada with the financial support of Health Canada (# 705166) to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publisher apologizes for the error.
  1 in total

1.  SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.

Authors:  Irakli Dzneladze; John F Woolley; Carla Rossell; Youqi Han; Ayesha Rashid; Michael Jain; Jüri Reimand; Mark D Minden; Leonardo Salmena
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.